Abstract
Alpha-smooth muscle actin (α-SMA) is the actin isoform that predominates within vascular smooth-muscle cells and plays an important role in fibrogenesis. On the other hand, c-Met is the receptor for hepatocyte growth factor (HGF), which plays a role in protection from injury and has anti-fibrogenetic effects. To clarify whether α-SMA and HGF are associated with the progression of renal injury in Henoch–Schönlein purpura nephritis (HSPN), we evaluated the renal expression of α-SMA and c-Met in HSPN patients. Patients were divided into three groups. Group 1 consisted of eight patients (male:female 4:4) with stage II or less in the classification of the International Study of Kidney Disease in Children (ISKDC), Group 2 consisted of 20 patients (male:female 11:9) with ISKDC stage III or greater and a good prognosis, and group 3 consisted of seven patients (male:female 3:4) with ISKDC stage III or greater and poor prognosis. Renal biopsy findings, including c-Met and α-SMA staining, were investigated for each group. At first biopsy, the mean scores for renal α-SMA and glomerular c-Met in groups 2 and 3 were higher than those in group 1, while mean scores for neither renal α-SMA nor glomerular c-Met differed between groups 2 and 3. At second biopsy, the mean scores for renal α-SMA staining in group 3 were higher than those in group 2, and mean score for glomerular c-Met staining in group 3 was lower than that in group 2. In groups 2 and 3, the mean scores for glomerular and interstitial α-SMA staining at first biopsy were correlated with the chronicity index (CI) at second biopsy, but the mean score for glomerular c-Met staining at first biopsy correlated with neither the activity index (AI) nor CI in the first or second biopsies in all groups. Our findings suggest that the expression of renal α-SMA may be associated with progression of renal injury in HSPN.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Habib R, Niaudet R, Levy M (1994) Schoenlein-Henoch purpura nephritis and IgA nephropathy. In: Tisher CC, Brenner BM (eds) Renal pathology with clinical and functional correlations, 2nd edn. Lippincott, Philadelphia, pp 427–523
Counahan R, Winterborn MH, White RHR (1977) Prognosis of Henoch–Schönlein nephritis in children. Br Med J 2:11–14
Haycock GB (1998) The nephritis of Henoch–Schönlein purpura. In: Cameron JS (ed) Oxford textbook of nephrology, 2nd edn. Oxford University Press, Oxford, pp 585–612
Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena P, Italian Group of Renal Immunopathology Collaborative Study on Henoch–Schonlein Purpura (1997) Long-term prognosis of Henoch–Schonlein nephritis in adults and children. Nephrol Dial Transplant 12:2277–2283
Sappino AP, Schurch W, Gabbiani G (1990) Differentiation repertoire of fibroblastic cells; expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 63:144–161
Alpers CE, Hudkins KL, Gown AM, Johnson RJ (1992) Enhanced expression of ‘muscle-specific’ actin in glomerulonephritis. Kidney Int 41:1134–1142
Nakamura T, Nishizawa T, Hagiya M, Seki T, Schimonishi M, Sugimura A, Tashiro K, Shimizu S (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342:440–443
Matsumoto K, Nakamura T (2001) Hepatocyte growth factor: renotropic role and potential therapeutics for renal disease. Kidney Int 59:2023–2038
Kawaida K, Natsumoto K, Shimazu H, Nakamura T (1994) Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Nati Acad Sci U S A 91:4357–4361
Miller SB, Martin DR, Kissane J, Hammeman MR (1994) Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol 266:F129–F134
Liu Y, Wikinson FL, Kirton JP, Jeziorska M, Lizasa H, Sai Y, Nakashima E, Heagerty AM, Canfield AE, Alexander MY (2007) Hepatocyte growth factor and c-Met expression in pericytes: implications for atherosclerotic plaque development. J Pathol 212:12–19
Meadow SR, Glasgow EF, White RHR (1972) Schönlein-Henoch nephritis. Q J Med 41:241–258
White RHR (1994) Henoch-Schönlein nephritis. A disease with significant late sequelae. Nephron 68:1–9
Zhang G, Moorhead PJ, El Nahas AM (1995) Myofibroblasts and the progression of experimental glomerulonephritis. Kidney Int 3:308–318
Goumenous D, Brown CB, Shortland J, El Nahas AM (1994) Myofibroblasts and the progression of mesangial IgA nephropathy. Nephrol Dial Transplant 9:1418–1425
Goumenos D, Tsomi K, Iatrou C, Oldroyd S, Sungur A, Papaioannides D, Moustakas G, Ziroyannis P, Mountokalakis T, El Nahas AM (1998) Myofibroblasts and the progression of crescentic glomerulonephritis. Nephrol Dial Transplant 13:1652–1661
Utsunomiya Y, Kawamura T, Abe A, Imai H, Hirano K, Maruyama N, Hosoya T, Sakai O (1999) Significance of mesangial expression of α-smooth muscle actin in the progression of IgA nephropathy. Am J Kidney Dis 34:902–910
Kawasaki Y, Suzuki J, Sakai N, Tanji M, Suzuki H (2003) Predicting the prognosis of renal dysfunction by renal expression of α-smooth muscle actin in children with MPGN type 1. Am J Kidney Dis 42:1131–1138
Cantley LG, Barros EJG, Gandhi M, Rauchman M, Nigam SK (1994) Regulation of mitogenesis, motogenesis, and tubulogenesis by hepatocyte growth factor in renal collecting duct cells. Am J Physiol 267:F271–F280
Rampino T, Gregorini M, Camussi G, Conaldi PG, Soccio G, Maggio M, Bottelli A, Canton AD (2005) Hepatocyte growth factor and its receptor Met are induced in crescentic glomerulonephritis. Nephrol Dial Transplant 20:1066–1074
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kawasaki, Y., Imaizumi, T., Matsuura, H. et al. Renal expression of alpha-smooth muscle actin and c-Met in children with Henoch–Schönlein purpura nephritis. Pediatr Nephrol 23, 913–919 (2008). https://doi.org/10.1007/s00467-008-0749-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-008-0749-6